Send feedback

AMN p.Leu258Ser

c.773T>C · rs190222721 · VCV695424

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 6 submitters
AlphaMissense
likely benign
0.0988 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.792%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
Imerslund-Grasbeck syndrome type 2

Computational evidence

Protein change
AlphaMissense0.0988likely benign
REVEL0.107moderately benign-leaning
SaProtLLR -3.76tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 1.8GERP -1.2, phastCons 1
Regional constrainto/e 1.06unconstrained · MANE · 7,988 bp · p 0.14 · regional, not allelic
Overall
CADD13.03PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.792% European (non-Finnish) · 9,088/1,147,124 alleles
Filtering AF 0.779% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.773%
Overall 0.661% 10,244/1,549,708 alleles · rare
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 1.1% 91
European (non-Finnish)grpmax 0.792% 126
Remaining individualsnot grpmax-eligible 0.478% 209
Admixed American 0.163% 615
Ashkenazi Jewishnot grpmax-eligible 0.126% 795
African / African-American 0.123% 813
Middle Eastern 0.0775% 1,290
South Asian 0.0107% 9,337

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
AMN
Protein
p.Leu258Ser
Coding
c.773T>C
MANE Select
NM_030943
dbSNP
rs190222721
Type
single nucleotide variant
Location
chr14:102929667 (GRCh38)
Gene constraint
LOEUF 1.446 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 80.78 · 1 PDB
Residue 258
a β-strand
Full AMN gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Imerslund-Grasbeck syndrome type 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: Imerslund-Grasbeck syndrome

For Imerslund-Gräsbeck syndrome (Orphanet):

Inheritance
Autosomal recessive
Onset
Childhood
Prevalence
1-9 / 1 000 000 (Finland)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/amn-p-leu258ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown